Theralase Technologies
Toronto
About Theralase Technologies
Theralase Technologies is a biopharmaceutical company focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical applications in patients. Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells and other disease states. The Therapeutic Laser Technology division is focused on the development and commercialization of laser-based non-invasive therapeutic devices to eliminate pain, reduce inflammation, and accelerate tissue healing. The Photo Dynamic Therapy division is focused on the discovery and development of small, light-activated molecules and companion laser systems that activate them with high anti-cancer effectiveness, microbial sterilization potency, and bacterial infection control.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $26.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: cve:TLT
- Website: theralase.com
- Phone: +1-866-843-5273
Industries & Categories
Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/theralase-technologies-13345 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.